Advertisement

Topics

Puma Biotechnology Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017

18:02 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced publication of abstracts on neratinib for the American Association for Cancer Research (AACR) Annual Meeting 2017. The AACR Annual Meeting will be h...

Other Sources for this Article

Puma Biotechnology, Inc.
Alan H. Auerbach or Mariann Ohanesian, +1 424-248-6500
info@pumabiotechnology.com
ir@pumabiotechnology.com
or
Russo Partners
David Schull or Darren Chia, +1 212-845-4242
david.schull@russopartnersllc.com
darren.chia@russopartnersllc.com

NEXT ARTICLE

More From BioPortfolio on "Puma Biotechnology Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...